 |
 |
|
|
RESÚMENES ABRIL 2006 |
Psychotic Disorders & Antipsychotics
(Haga un click en la información del journal
para acceder al resúmen)
The SOHO (Schizophrenia
Outpatient Health Outcome) Study: Implications for the Treatment of
Schizophrenia
Haro, Josep
Maria; Salvador-Carulla, Luis
CNS
Drugs. 20(4):293-301, 2006
ECT for Treatment-Resistant Schizophrenia: A
Response from the Far East to the
Chanpattana, Worrawat;
Andrade, Chittaranjan
Journal of ECT. 22(1):4-12,
March 2006
Combined Use of Electroconvulsive Therapy and Antipsychotics in Schizophrenia: the Indian Evidence. A
Review and a Meta-analysis
Painuly, Nitesh;
Chakrabarti, Subho
Journal of ECT.
22(1):59-66, March 2006
Electroconvulsive Therapy in First-Episode
Schizophrenia
Ucok, Alp; Cakr,
Sibel
Journal of ECT.
22(1):38-42, March 2006
A 24-Week Randomized Study of Olanzapine
Versus Ziprasidone in the Treatment of Schizophrenia
or Schizoaffective Disorder in Patients with Prominent Depressive Symptoms
Kinon, Bruce J.; Lipkovich,
Ilya; Edwards, S. Beth; Adams, David H.; Ascher-Svanum, Haya; Siris, Samuel G
Journal of Clinical
Psychopharmacology. 26(2):157-162, April 2006
Risk of Mortality Associated with Antipsychotic and
Other Neuropsychiatric Drugs in Pneumonia Patients
Barnett, Mitchell J.;
Perry, Paul J.; Alexander, Bruce; Kaboli, Peter J
Journal of Clinical
Psychopharmacology. 26(2):182-187, April 2006
Jorge L. Armenteros and Mark Davies
European
Child & Adolescent Psychiatry 2006; Volume 15, Number 3: 141 - 148
Darryl Wade, Susy Harrigan, Meredith G. Harris, Jane Edwards, Patrick D. McGorry
Psychiatric Bulletin (2006) 30: 127-131
Serum
concentrations of clozapine and norclozapine
in the prediction of relapse of patients with schizophrenia
Ying-Qiang Xiang, Zhang-Jin Zhang, Yong-Zhen Weng,
Yi-Min Zhai, Wen-Biao Li, Zhuo-Ji Cai, Qing-Rong Tan and Chuan-Yue Wang
Schizophrenia
Research. Volume 83, Issues 2-3, April 2006, Pages 201-210
Smoking
is associated with schizophrenia, but not with mood disorders, within a
population with low smoking rates: A matched case–control study in
Adalberto Campo-Arias, Luis A. Díaz-Martínez, Germán E. Rueda-Jaimes, Mauricio Rueda-Sánchez,
Daniel Farelo-Palacín, Francisco J. Diaz and Jose de
Leon
Schizophrenia
Research. Volume 83, Issues 2-3, April 2006, Pages 269-276
C.
Daniel Mullins, Fadia T. Shaya,
Julie Magno Zito, Nour Obeidat, John Naradzay and David J. Harrison
Schizophrenia
Research. Volume 83, Issues 2-3, April 2006, Pages 277-284
Amie T.
Joyce, David J. Harrison, Antony D. Loebel, Chureen T. Carter and Daniel A. Ollendorf
Schizophrenia
Research. Volume 83, Issues 2-3, April 2006, Pages 285-292
Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment
Joseph P. McEvoy, Jeffrey A.
Lieberman, T. Scott Stroup, Sonia M. Davis, Herbert Y. Meltzer, Robert A. Rosenheck, Marvin S. Swartz, Diana O. Perkins, Richard S.E.
Keefe, Clarence E. Davis, Joanne Severe, John K. Hsiao, for the CATIE
Investigators
American
Journal of Psychiatry 163:600-610, April 2006
Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic
T. Scott Stroup, Jeffrey A. Lieberman, Joseph P. McEvoy, Marvin S. Swartz, Sonia M. Davis, Robert A. Rosenheck, Diana O. Perkins, Richard S.E. Keefe, Clarence
E. Davis, Joanne Severe, John K. Hsiao, for the CATIE Investigators
American
Journal of Psychiatry 163:611-622, April 2006
Robin Emsley, Jonathan Rabinowitz, and Rossella Medori
American Journal of
Psychiatry 163:743-745, April 2006
Diana I Brixner, Qayyim Said, Patricia K Corey-Lisle, A Vickie Tuomari, Gilbert J L'Italien,
William Stockdale, Gary M Oderda
The Annals of Pharmacotherapy: Vol. 40, No. 4, pp.
626-632
Peter FJ Schulte
The Annals of Pharmacotherapy:
Vol. 40, No. 4, pp. 683-688
Differing Effects of
Antipsychotic Medications on Substance Abuse Treatment Patients with
Co-occurring Psychotic and Substance Abuse Disorders
Elizabeth
B. Stuyt, Terrie A. Sajbel,
Michael H. Allen
Plasma antipsychotic concentration and receptor
occupancy, with special focus on risperidone
long-acting injectable
Rossella Medori,
Erik Mannaert and Gerhard Gründer
European Neuropsychopharmacology.
Volume 16, Issue 4, May 2006, Pages 233-240
Dopamine
D2 receptor gene variants and quantitative measures of positive and negative
symptom response following clozapine treatment
Rudi
Hwang, Takahiro Shinkai, Vincenzo
Deluca, Fabio Macciardi, Steven Potkin,
Herbert Y. Meltzer and James L. Kennedy
European Neuropsychopharmacology.
Volume 16, Issue 4, May 2006, Pages 248-259
Elevated
serum superoxide dismutase
and thiobarbituric acid reactive substances in
schizophrenia: A study of patients treated with haloperidol or clozapine
Clarissa
Severino Gama, Mirian
Salvador, Ana Cristina Andreazza, Flavio
Kapczinski and Paulo Silva Belmonte-de-Abreu
Todd Lencz, Christopher W. Smith, Danielle McLaughlin, Andrea Auther, Emilie Nakayama, Lauren Hovey and Barbara A. Cornblatt
Biological Psychiatry. Volume 59, Issue 9, 1 May 2006, Pages
863-871
The long-term level of
functioning in patients admitted for psychotic disorders with and without
substance abuse
Turid Møller
and Olav M. Linaker
Nordic
Journal of Psychiatry. Volume 60, Number 02 / March 2006: 121 - 125
Antipsychotic medication
and length of stay at a psychiatric maximum-security unit in
Sabine Renkel and Kirsten Rasmussen
Nordic
Journal of Psychiatry. Volume 60, Number 02 / March 2006: 132 - 136
C. Fendri, A. Mechri, G. Khiari, A. Othman, A. Kerkeni, L.
Gaha
L’encephale. Vol 32 - N° 2 - Avril 2006: 244 - 252
J. Micallef, E. Fakra, O. Blin
L’encephale. Vol 32 - N° 2 - Avril 2006: 263 - 269
Review: longer duration of untreated psychosis is associated with worse outcome in people with first episode psychosis
Diana O
Perkins
Evidence-Based
Mental Health 2006;9:36
Weight Management Program for Treatment-Emergent Weight Gain in Olanzapine-Treated Patients With Schizophrenia or Schizoaffective Disorder: A 12-Week Randomized Controlled Clinical Trial
Jun Soo Kwon, Jung-Seok Choi, Won-Myoung Bahk, Chang Yoon Kim, Chan Hyung
Kim, Young Chul Shin, Byung-Joo
Park, and Chang Geun Oh
J Clin Psychiatry
2006;67:547-553
Metabolic Syndrome and the Risk of Coronary Heart Disease in 367 Patients Treated With Second-Generation Antipsychotic Drugs
J Clin Psychiatry
2006;67:575-583
Involvement
of adenosine in the neurobiology of schizophrenia and its therapeutic
implications
Diogo R. Lara, Oscar P. Dall'Igna, Eduardo S. Ghisolfi
and Miriam G. Brunstein
The
relationship between prolactin response and clinical
efficacy of risperidone in acute psychotic inpatients
Bun-Hee Lee and Yong-Ku Kim
Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: A pilot study
Bun-Hee Lee, Yong-Ku Kim and